Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...
4don MSN
The best Persona games, ranked
With Persona 3 Reload and Persona 5 Royal released, we rank the 12 best Persona games to see how the classics stack up ...
MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License ...
Platform-specific achievement systems transformed an isolated gameplay preference into a visible, competitive subculture. What emerged wasn’t just a playstyle but an ecosystem of tracking tools, ...
The head of the Department of Health and Human Services has spent decades promoting vaccine skepticism and has now revamped the US childhood immunization schedule to have one-third fewer recommended ...
Recent research published in the journal Political Behavior shows that Americans largely prioritize the severity of a violent ...
It wasn't exactly a surprise after months of leaks and speculation, but Nvidia CEO Jensen Huang (in perhaps his finest ...
Coupling biomarker-guided screening with a targeted treatment bundle reduced newborn mortality, hospital stays, and other complications over standard care, according to a recent study.
There are hundreds of cell types in the human body, each with a specific role spelled out in their DNA. In theory, all it ...
Microsoft alone runs approximately 100,000 A/B tests each year to continuously optimize products. A famous Gmail experiment, ...
LOUISVILLE, Ky. (WDRB) -- A stretch of land beneath the Watterson Expressway is set to become Louisville’s newest outdoor recreation space. Planning and design are complete for Bike Highland Park, a ...
Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results